Wernike’s migraine (Hemiplegic migraine) - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Wernicke’s Migraine (Hemiplegic Migraine) – A Complete Guide

Wernicke’s Migraine (Hemiplegic Migraine) – A Complete Guide

Overview

Wernicke’s migraine, more commonly called hemiplegic migraine (HM), is a rare subtype of migraine that produces temporary weakness or paralysis (hemiplegia) on one side of the body during an attack. The condition can be inherited (familial hemiplegic migraine, FHM) or occur without a known family history (sporadic hemiplegic migraine, SHM).

Key facts

  • Prevalence: ≈0.01–0.03 % of the general population (about 1–3 per 10,000 people) [Mayo Clinic].
  • Typical onset: late childhood to early adulthood, but cases have been reported at any age.
  • Gender distribution: Slight female predominance (≈60 % women), mirroring classic migraine patterns.
  • Genetics: Mutations in CACNA1A, ATP1A2, or SCN1A genes account for ≈30–50 % of familial cases.

Symptoms

Symptoms develop in stages and can last from minutes to several days. The hallmark is a reversible motor deficit, but many other migraine features accompany it.

Prodrome (30 min–2 h before headache)

  • Aura – visual disturbances (flashing lights, zig‑zag lines), sensory changes (tingling, numbness), or speech difficulty.
  • Difficulty concentrating, mood changes, yawn attacks.

Acute attack

  • Hemiplegia – weakness or paralysis affecting the arm, leg, or face on one side. Weakness is usually moderate and improves within 24 h.
  • Headache – throbbing or pounding pain, often unilateral, lasting 4–72 h.
  • Neurological signs – ataxia (poor coordination), dysarthria (slurred speech), vertigo, diplopia (double vision), or auditory hypersensitivity.
  • Other migraine features – nausea, vomiting, photophobia, phonophobia.
  • Post‑ictal fatigue – profound tiredness lasting up to several days.

Resolution phase

  • Motor symptoms gradually return to baseline.
  • Residual headache or mild weakness may linger for up to 24 h.

Causes and Risk Factors

Genetic mutations

Up to half of familial hemiplegic migraine cases are linked to the following genes:

  • CACNA1A – encodes a neuronal calcium channel; also implicated in episodic ataxia and spinocerebellar ataxia.
  • ATP1A2 – encodes a sodium‑potassium pump subunit; mutations cause altered ion homeostasis.
  • SCN1A – encodes a voltage‑gated sodium channel; also involved in some epilepsy syndromes.

Non‑genetic triggers

  • Stress, lack of sleep, hormonal fluctuations.
  • Bright or flickering lights, strong odors, certain foods (caffeine, aged cheese, MSG).
  • Physical exertion, especially vigorous exercise.
  • Medication overuse (e.g., triptans, NSAIDs) can increase attack frequency.

Who is at higher risk?

  • Individuals with a family member diagnosed with HM.
  • People with a personal history of classic migraine with aura.
  • Those who carry known pathogenic mutations (identified via genetic testing).

Diagnosis

Diagnosing hemiplegic migraine relies on careful clinical assessment and exclusion of other serious neurological conditions.

Clinical criteria (International Classification of Headache Disorders – ICHD‑3)

  • At least two migraine attacks with reversible motor weakness.
  • Accompanied by at least one typical migraine feature (headache, photophobia, nausea, aura).
  • Full recovery of neurological deficits within 24 h.

Diagnostic work‑up

  • Neuroimaging – MRI (often with diffusion‑weighted sequences) to rule out stroke, tumor, or demyelinating disease. In HM, MRI is usually normal or may show transient cortical edema during an attack.
  • CT scan – quick screening for acute hemorrhage if stroke is a concern.
  • Electroencephalogram (EEG) – to exclude seizures when the presentation is atypical.
  • Genetic testing – targeted panels for CACNA1A, ATP1A2, SCN1A; recommended for patients with a positive family history or recurrent severe attacks.
  • Blood work – basic metabolic panel, CBC, and inflammatory markers to exclude infection or metabolic causes of weakness.

Treatment Options

Treatment aims to abort acute attacks, prevent recurrence, and minimize disability.

Acute‑phase medications

  • Triptans – historically avoided due to concerns of vasoconstriction, but recent case series suggest they can be used cautiously in low‑risk patients. Use only under neurologist supervision.
  • Intravenous magnesium sulfate (1–2 g over 15 min) – may reduce aura severity and improve motor symptoms.
  • Anti‑emetics – ondansetron or metoclopramide for nausea/vomiting.
  • Analgesics – acetaminophen or low‑dose NSAIDs; avoid high‑dose aspirin (risk of Reye‑like syndrome).
  • Intravenous lidocaine – limited data, used in refractory cases under intensive care monitoring.

Preventive (prophylactic) therapies

  • Calcium channel blockers – verapamil (240–480 mg/day) shown to reduce attack frequency.
  • Antiepileptic drugs –
    • Topiramate (25–100 mg/day) – effective for migraine with aura.
    • Valproic acid (500–1500 mg/day) – especially useful in patients with comorbid epilepsy.
  • Beta‑blockers – propranolol (80–240 mg/day) may help when cardiovascular risk is low.
  • Acetazolamide – carbonic anhydrase inhibitor; useful in CACNA1A‑related cases.
  • Antibody therapy – CGRP monoclonal antibodies (erenumab, fremanezumab) are emerging options; limited but promising data for HM.

Procedural interventions

  • Occipital nerve stimulation – anecdotal benefits in refractory cases.
  • Botulinum toxin type A – primarily for chronic migraine; may help some HM patients.

Lifestyle & non‑pharmacologic measures

  • Identify and avoid personal triggers (keep a migraine diary).
  • Regular sleep schedule (7–9 h/night).
  • Stress‑reduction techniques: mindfulness, yoga, progressive muscle relaxation.
  • Hydration: 2–3 L of water daily.
  • Limit caffeine to ≤200 mg/day.
  • Consistent aerobic exercise (moderate intensity, 150 min/week) – improves migraine control.

Living with Wernicke’s Migraine (Hemiplegic Migraine)

Because attacks can cause temporary disability, planning ahead is essential.

  • Carry a “migraine passport” – brief note outlining diagnosis, typical symptoms, and emergency contacts for use at work or school.
  • Set up a safe environment – keep sturdy furniture, remove tripping hazards, and have a designated “rest area” for attacks.
  • Inform close contacts – family, friends, and coworkers should know that temporary weakness is part of the migraine and not a stroke.
  • Medication kit – keep acute meds, anti‑emetics, and a hydration solution (electrolyte drink) readily available.
  • Regular follow‑up – at least every 6–12 months with a neurologist familiar with HM.

Prevention

Proactive steps can markedly reduce attack frequency.

  1. Trigger management – use a diary to pinpoint foods, stressors, or hormonal patterns that precede attacks.
  2. Medication adherence – take preventive drugs exactly as prescribed; do not stop abruptly.
  3. Vaccinations & infection control – febrile illnesses can precipitate attacks; stay up‑to‑date on flu and COVID‑19 vaccines.
  4. Nutrition – balanced diet rich in magnesium (leafy greens, nuts) and riboflavin (whole grains, dairy) may have modest migraine‑preventive effects.
  5. Sleep hygiene – avoid night‑time screen exposure and maintain a consistent bedtime.
  6. Hormonal considerations – for women, discuss menstrual‑related migraine management with a provider (e.g., continuous estrogen therapy).

Complications

When untreated or misdiagnosed, HM can lead to serious outcomes.

  • Persistent neurological deficit – rare but reported after prolonged, untreated attacks.
  • Stroke mimics – repeated attacks may cause cortical spreading depression leading to ischemic‑like lesions visible on MRI.
  • Depression & anxiety – chronic disability can affect mental health.
  • Medication overuse headache – frequent use of analgesics may transform episodic migraine into chronic daily headache.
  • Reduced quality of life – impacts work, education, and social activities.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following during a migraine attack:

  • Sudden onset of weakness that does not improve within 30 minutes.
  • New or worsening speech difficulty (aphasia) or facial droop.
  • Severe, “worst‑ever” headache, especially if accompanied by fever, stiff neck, or altered consciousness.
  • Vision loss or double vision that persists.
  • Seizure activity.
  • Rapidly progressing neurological symptoms (e.g., weakness spreading to the other side of the body).

These signs could indicate a stroke, intracranial hemorrhage, or other life‑threatening condition that requires immediate evaluation.

References

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References